At insitro, we combine 20+ petabytes of automated cellular experiments with population-scale genetics to build Physical AI systems that reveal the true causal drivers of human disease and deliver targeted therapeutics.
insitro’s Virtual HumanTM is built on the world’s largest integrated multimodal corpus of human clinical and cellular data. It is a genetically anchored, causal AI engine that reveals how disease begins, progresses, and can be resolved—precisely identifying causal disease targets prior to candidate optimization.
TherMLTM is insitro’s modality-agnostic, AI-driven therapeutics design engine, spanning small molecules, oligonucleotides, and complex biologics. By matching the best-fit modality to each target and indication, TherML shifts drug discovery from stochastic screening to predictive, adaptive engineering—advancing better molecules, faster.
We’ve built a unique culture where life scientists, data scientists, engineers, and drug hunters work together to identify the most important questions, design and scale experiments, build models, and analyze the results. Our differences enhance our strengths, and our collective expertise comes together to generate scientific breakthroughs.